Accelerating Clinical Trials in Asia 2018 2nd Annual Accelerating Clinical Trials in Asia 2018
Download Brochure Request

Register your interest

Comments

Register your interest

Comments

2nd Annual Accelerating Clinical Trials in Asia 2018

18-21 Sep 2018, Singapore

Book Now

SPECIAL 1-FOR-1 OFFER ON NORMAL RATES FOR PHARMACEUTICAL COMPANIES*
LIMITED SEATS ONLY, VALID UNTIL 29 JUNE 2018. SEE PRICING BELOW FOR MORE INFORMATION.

overview

The ONLY senior platform focused at clinical operational excellence Singapore, the Accelerating Clinical Trials in Asia zeroes in on the key operational and executional challenges in the burgeoning trial markets within Asia Pacific. Balanced with commercial information on Pharma spend areas and growth segments, this is your one stop shop to accelerate cost-efficient clinical development.

“Good networking opportunities with amazing people in the industry. This is my first conference and looking forward for more.”
Nur Farhana Muhamad, Market Analyst, Pharmaniaga Berhad

Conference Highlights

  • Global Pharma Spend areas – And plans for the Asian Clinical Trial market
  • Regional Government – Incentives, Investment, and Collaboration opportunities
  • KOL Engagement – And demonstrating value of Trial Protocols
  • Technology and Analytics – In practice, and how they are impacting trials
  • Compliance, Quality and Audits – Case studies and real world examples
  • Budgeting, Site Selection and Project Management – Working effectively with 3rd parties

Part of

Pharmacon Asia >>

Co-Located Events

Accelerating Clinical Trials in Asia >>
Pharma Regulatory Affairs Summit >>
Pharma Market Access and Pricing Summit Asia >>

agenda

8:00 am

Registration and Networking Session

9:00 am

Chairperson’s Opening Remarks

PHARMACON ASIA OPENING PLENARY SESSION

9:05 am

[Industry Address] Future of Pharma – Adapting Business Models in the Age of Analytics, Data Sciences and Machine Learning

9:30 am

[Innovation Talk] Innovation and Digitalisation – The Impact and Where Do We Go Next?

Dan Wang, Head, Johnson & Johnson Innovation Asia-Pacific, China

10:00 am

  • Drug pipeline growth areas
  • Regulatory trends
  • Innovation in pricing and market access
  • The most significant industry trends in the long term, and how should Pharma respond

10:40 am

Morning Networking and Refreshment Break

End of opening Plenary and 2nd Annual Clinical Trials in Asia Commence

11:10 am

Chairperson’s Opening Remarks

TECH IN TRIALS

11:15 am

  • How are digital platforms shaping clinical trials operations?
  • How can we use digital platforms to improve and accelerate clinical trials?
  • Leveraging AI for a paradigm shift in clinical research
  • Patient engagement and the democratisation of clinical trial information
  • Cutting – edge technology to match the right patients with the right trials

11:45 am

  • Intelligent trials – the Road to successfully operating trials in digital platforms
  • Harnessing the power of data intelligence
  • Challenges and opportunities in clinical trials operations
  • Embracing change – organisation-wide and partner management
  • Future of clinical trials modernization in Asia

12:30 pm

  • Collecting, processing and analysing data in real-time
  • Implementation obstacles on data quality, standards, and integration with other data sources
  • Leveraging mobile, social media, cloud and big data platforms to ensure better patient outcomes

1:00 pm

Networking Lunch

2:00 pm

  • Enabling digital workforce enterprise-wide
  • Improving patient enrollment and engagement
  • Smart decisions based on data-driven facts
  • Improving outcomes for patients and R&D

CLINICAL TRIAL MARKETS

2:30 pm

  • What is “Investigator-led” oncology trials compared to the traditional pharma sponsored trials?
  • Examples of some of the “Investigator-led” oncology trials
  • Value of “Investigator-led” oncology trials for society

3:30 pm

Afternoon Networking and Refreshment Break

4:00 pm

  • Business case of approval and hospital permit highlights
  • Providing support / cooperation (funding, sponsored drugs/ medications)
  • Patient and subjects: Demography, Recruitment
  • The role of local coordinator: overcoming language and cultural barrier
  • Step by step approach in succeeding in Indonesia

4:30 pm

  • Challenges and opportunities for clinical research in Malaysia
  • Advantage in investigations, patient population, infrastructure
  • Facilities, infrastructure and personnel in healthcare system
  • Ethical concerns, approval process and regulations for clinical research
  • Clinical research leaders’ recruitment expertise
  • Optimizing patient recruitment
  • Best practices that can be used to ensure patients’ compliance
  • Best practices in selecting clinical research sites

5:30 pm

Chairperson’s Summary of the Day and End of Conference Day 1

9:00 am

Chairperson’s Opening Remarks

OPTIMISING TRIAL OUTCOMES

9:05 am

Redefining the CRO Value Add

Jessica Thongcharen, Director GPV - Clinical Development Services, Takeda, Singapore

9:30 pm

  • Current trends and challenges
  • Increasing patient involvement
  • Gaining a deeper understanding of the patient experience
  • New technologies assisting patient centricity

10:10 am

  • Framework of good practices for global project management
  • Managing external and internal teams
  • Stakeholder management through CROs
  • Overall outsourcing project Management

10:40 am

Morning Networking and Refreshment Break

11:10 am

CRO’s Perspective: Digitalisation Impact Areas – Trial Design, Patient Recruitment, Patient Centricity, Site Monitoring, Big Data Analytics, Cloud Based Clinical Data Warehouses

11:40 am

  • Conditional approval – an emerging as a paradigm to speed up drug development and accessibility to new critical treatments
  • Key merits and criticalities of this approach

DISEASE SPECIFIC TRIALS

12:10 pm

Improving Clinical Outcomes on Liver Cancer

Pierce Chow, Professor Duke-NUS Graduate Medical School/Senior Consultant, Division of Surgical Oncology, National Cancer Centre Singapore / Senior Consultant, Department of Hepatopancreatobiliary/Transplant Surgery, Singapore General Hospital

12:30 pm

Networking Lunch

1:30 pm

Cancer Immunotherapy Clinical Trials including Cancer Vaccines and Cellular Therapy (topic TBC)

Dr. Anggun Ramayudantha, Vitreoretina Specialist and Lecturer in Dept. of Ophthalmology, Faculty of Medicine Universitas Indonesia

2:00 pm

Case Study in Infectious Disease Using Molecular Endpoints to Accelerate Clinical Trials through the Development of Molecular Endpoints

Raphael Zellweger, Scientific Director, The Viral Research and Experimental Medicine Centre @ SingHealth Duke-NUS (ViREMiCS)

INNOVATION IN CRITICAL TREATMENT TRIALS

2:30 pm

  • Opportunity and business expansion
  • Regulatory challenges and applications
  • Technology and site selection
  • Cost control and managing project
  • Case study

3:00 pm

  • Speeding up studies with eTMF Systems
  • Trial Management when TMF subcontracted to CRO
  • Organising TMF when the trial is multi-country or multi-centre
  • Trial data storage, security and quality

3:30 pm

Afternoon Networking and Refreshment Break

CLOSING PLENARY SESSION

4:10 pm

  • Top line innovation trends and implications
  • Drug research and development environment in the long term
  • Impact of M&A activity and investment on industry
  • Emerging pharma business models, broadening value propositions, and sustainable revenue models

5:00 pm

Chairperson’s Summary of the Day and End of Conference

pricing

Packages Price
2 Day ConferenceSGD $2895SGD $2695Early BirdEarly Bird

Early Bird Rate: Register & Pay by 20 July 2018

Special 1-for-1 Offer on Normal Rates for Pharmaceutical Companies*
Limited seats only, valid until 29 June 2018, email register@ibcasia.com.sg to find out more!

*The organizer reserves the right to determine the industry to which your company belongs, and to stop the promotion at any stage.

GROUP SAVINGS:
Register 2 Delegates and get 1 FREE PASS
Register 3 Delegates and get 2 FREE PASS
(Group rate is based on normal rate of 2-day main conference package only)

For Group Registrations of more than 3 team members,
email info@ibcasia.com.sg or call +65 6508 2477

  • Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time.
  • Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR group rate.
  • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
  • All delegates from Singapore-based companies are required to pay an additional 7% GST (SINGAPORE EVENTS ONLY)

Sponsorship

Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>

Register Your Interest

Receive updates on this event. Leave your details with us and we will notify you of updates as they happen.

Register your interest here >>

speakers

Dan Wang

Head, Johnson & Johnson Innovation Asia-Pacific, China

Enver Erkan

Country Manager, Pfizer Singapore

Alexis Sterlin

Asia Cluster Head, Novartis

Rajkumar Narayanan

President Asia, Alcon

Pablo Graiver

Co-founder & CEO, Antidote, United Kingdom

Dr Aaron Tabensky

Director, Clinical Trial Management, Asia Pacific, Abbott Laboratories

Clarence Khoo

Associate Director, Clinical Operations, Takeda Development Center (Asia)

Ajay Tiku

Vice President Medical & Clinical, Asia Pacific, Glaxo Smith Kline, Singapore

Senior Representative, IQVIA

Fuqu Wang

Director, R&D Operations Innovation Leader, The Janssen Pharmaceutical, United States

Teoh Yee Leong

Chief Executive Officer, Singapore Clinical Research Institute

Hazel Dy Tioco

Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines

Dr. Martin Hertanto

Dept. of Ophthalmology, Faculty of Medicine Universitas Indonesia

Pei Chien Tah

Principal Investigator, University Malaya Medical Centre, Malaysia

Naresh Gupta

M.D., Director- Professor, Maulana Azad Medical College, Chief, Haemophilia Centre &Network Coordinator for Haemophilia, India, Principal Investigator, Maulana Azad Medical College & Lok Nayak Hospital

Dr Yong Soon-Leong

Obstetrician & Gynaecologist & Clinical Researcher, Sibu Hospital, Sarawak, Malaysia

Dr. Anggun Ramayudantha

Vitreoretina Specialist and Lecturer in Dept. of Ophthalmology, Faculty of Medicine Universitas Indonesia

Jessica Thongcharen

Director GPV - Clinical Development Services, Takeda, Singapore

Alex Goh

Senior Manager, Regional Clinical Quality and Medical Quality, Asia Pacific, GSK, Singapore

Sow Wei Wong

Legal Counsel Takeda Global Research & Development Centre (Asia)

Yongho Oh

Regional Clinical PM and ISS PM for Asia, JPAC & China, Sanofi Pasteur, Singapore

Vincenzo Teneggi

Senior Medical Director, D3 (Drug Discover & Development) A*STAR, Singapore

Pierce Chow

Professor Duke-NUS Graduate Medical School/Senior Consultant, Division of Surgical Oncology, National Cancer Centre Singapore / Senior Consultant, Department of Hepatopancreatobiliary/Transplant Surgery, Singapore General Hospital

Raphael Zellweger

Scientific Director, The Viral Research and Experimental Medicine Centre @ SingHealth Duke-NUS (ViREMiCS)

when & where

18 - 21 Sep 2018

Singapore

contact

Still have a question?

Speaking Opportunities
Sophia Zhao
+65-6508 2491
 
sophia.zhao@ibcasia.com.sg

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489

Yvonne.Leong@ibcasia.com.sg

Media & Association Partnership Opportunities
June Tan
+65 6508 2465
June.Tan@ibcasia.com.sg

exhibitors

STAY UPDATED ON OUR NEWS & EVENTS

IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more